Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 3, 2015
Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapyFrancesco Moccia, Estella Zuccolo, Valentina Poletto, et al.
Plastic and Reconstructive Surgery. Global Open|November 2, 2020
Laparoscopically Assisted Transperineal Approach in the Management of a Giant Pelvic LipomaAlessio Baccarani, Elisa Bonetti, Antonio Pedone, et al.
Current Vascular Pharmacology|June 26, 2012
Ca2+ signalling in endothelial progenitor cells: a novel means to improve cell-based therapy and impair tumour vascularisationFrancesco Moccia, Francesco Lodola, Silvia Dragoni, et al.
Cytokine|August 31, 2010
Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosisRita Campanelli, Vittorio Rosti, Laura Villani, et al.
Plos One|April 5, 2013
JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosisGiovanni Barosi, Valentina Poletto, Margherita Massa, et al.
European Journal of Haematology|December 18, 2007
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromesErica Travaglino, Chiara Benatti, Luca Malcovati, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2020
Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell TransplantationMatteo Chinello, Rita Balter, Massimiliano De Bortoli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2019
Synergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative NeoplasmsPritesh R Patel, Vitalyi Senyuk, Natalie S Rodriguez, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphomaPaolo G Gobbi, Vittorio Rosti, Francesco Valentino, et al.
Frontiers in Pediatrics|May 13, 2025
Case Report: Severe hemophilia B patient with inhibitor and anaphylaxis reaction to FIX, successfully managed with concizumab prophylaxis therapyElisa Bonetti, Maria Pia Esposto, Ada Zaccaron, et al.
Pageof 5